Acro Biomedical Co., Ltd. financial data

Location
12175 Visionary Way, Suite 1160, Fishers, IN
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 55.8 %
Debt-to-equity -115 %
Return On Equity 15.6 % -97.5%
Return On Assets -125 % +96.7%
Operating Margin -3.53K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60M shares
Common Stock, Shares, Outstanding 60M shares 0%
Common Stock, Value, Issued 60K USD 0%
Weighted Average Number of Shares Outstanding, Diluted 60M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD -100%
Research and Development Expense 0 USD -100%
Operating Income (Loss) -41.1K USD +97.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -46.8K USD +97.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -46.8K USD +97.1%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 39.6K USD
Operating Lease, Right-of-Use Asset 13.7K USD -65.7%
Assets 53.3K USD +17.7%
Liabilities, Current 371K USD +20.4%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 327K USD +3.64%
Retained Earnings (Accumulated Deficit) -32.7M USD -0.14%
Stockholders' Equity Attributable to Parent -318K USD -14.9%
Liabilities and Equity 53.3K USD +17.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.5K USD -66.7%
Net Cash Provided by (Used in) Financing Activities 22.3K USD +67.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 60M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 26 USD -97.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 6.87M USD +0.12%
Operating Lease, Liability 13.7K USD -65.7%
Lessee, Operating Lease, Liability, to be Paid 13.9K USD -66.7%
Operating Lease, Liability, Current 13.7K USD -47.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 27.8K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 18.5K USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 239 USD -87.5%
Deferred Tax Assets, Operating Loss Carryforwards 6.87M USD +0.12%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Additional Paid in Capital 32.3M USD +0.02%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%